Literature DB >> 22490815

[The association of vitamin D receptor gene ApaI and BsmI polymorphism with systemic lupus erythematosus].

Xiong-yan Luo1, Li-jun Wu, Long Chen, Ming-hui Yang, Tao Liao, Ning-tao Liu, Banjiang Ku-Er, Chuan-mei Xie, Ran-geng Shi, Zhong Tang, Yan Zhao, Xiao-feng Zeng, Guo-hua Yuan.   

Abstract

OBJECTIVE: To determine the distribution of vitamin D receptor (VDR) gene ApaI and BsmI polymorphism in systemic lupus erythematosus (SLE) and the association with SLE in Chinese Han patients.
METHODS: Genomic DNA from 244 Chinese SLE patients and 162 sex and ethnically matched controls were typed for VDR ApaI and BsmI polymorphism combination by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Clinical characteristics were analyzed between different ApaI and BsmI genotypes.
RESULTS: There was no significant difference between the distribution frequencies of allelic gene A and a in SLE patients and the controls, but the distribution frequency of genotypes heterozygote Aa in SLE patients was higher than that in the controls (38.9% vs 22.2%, χ(2) = 12.442, P = 0.000). There was no significant difference between the distribution frequency of allelic gene and genotypes of BsmI in SLE patients and the controls (P > 0.05). However, there was significant difference between the distribution frequencies of ApaI and BsmI genotypes combination in SLE patients and the controls (χ(2) = 18.226, P = 0.006). The distribution frequency of genotypes Aa-bb in SLE patients was higher than that in the controls (32.4% vs 17.9%, χ(2) = 10.449 P = 0.001), while the distribution frequency of genotypes Aa-bb in SLE patients was lower than that in the controls (30.3% vs 42.0%, χ(2) = 5.808, P = 0.016). Furthermore, analyzing the effect of VDR ApaI and BsmI polymorphism combination to the symptoms of SLE, significant difference was observed in SLE patients carrying Aa-bb genotypes involved in serositis (P = 0.003), hematological system disorder (P = 0.021), and anti-Sm antibodies (P = 0.01) compared with other genotypes.
CONCLUSION: There is significant association between ApaI and BsmI gene polymorphism Aa-bb genotypes and the incidence of SLE in the Han population of China, and genotype Aa-bb is more involved in serositis, hematological system disorder and has a positive effect on production of antibodies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22490815

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  5 in total

1.  Role of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D level in Egyptian female patients with systemic lupus erythematosus.

Authors:  Ahmed A Emerah; Amal S El-Shal
Journal:  Mol Biol Rep       Date:  2013-09-21       Impact factor: 2.316

2.  Association between vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus: a meta-analysis.

Authors:  Song Mao; Songming Huang
Journal:  Rheumatol Int       Date:  2013-11-09       Impact factor: 2.631

3.  Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations.

Authors:  De Azevêdo Silva J; Addobbati C; Sandrin-Garcia P; Crovella S
Journal:  Curr Genomics       Date:  2014-02       Impact factor: 2.236

4.  Vitamin D receptor gene polymorphisms and haplotypes in Hungarian patients with idiopathic inflammatory myopathy.

Authors:  Levente Bodoki; Ji-Qing Chen; Margit Zeher; Melinda Nagy-Vincze; Zoltán Griger; Erika Zilahi; Katalin Dankó
Journal:  Biomed Res Int       Date:  2015-01-14       Impact factor: 3.411

5.  Vitamin D receptor gene BsmI polymorphisms in Egyptian children and adolescents with systemic lupus erythematosus: A case-control study.

Authors:  Seham F Azab; Yasser F Ali; Mohsen A A Farghaly; Mohammed E Hamed; Mayy A N Allah; Ahmed A Emam; Nasser I Abdelsalam; Mustafa I A Hashem; Heba H Gawish; Rehab M Nabil; Lamiaa M Kamel; Dalia S Fahmy; Salah F Alsayed; Nashwa M Al Azizi; Ghada M Al-Akad; Maha A Noah; Hind M Abdelrahman; Ahmed R Ahmed; Eman A Bendary
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.